Chemical compounds

Details for Australian Patent Application No. 2004232527 (hide)

Owner AstraZeneca AB

Inventors Mortlock, Andrew Austen; Heron, Nicola Murdoch; Jung, Frederic Henri; Pasquet, Georges Rene

Agent Davies Collison Cave

Pub. Number AU-A-2004232527

PCT Pub. Number WO2004/094410

Priority 03290951.7 16.04.03 EP

Filing date 14 April 2004

Wipo publication date 4 November 2004

International Classifications

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61P 035/00 Antineoplastic agents

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/094410 Priority application(s): WO2004/094410

18 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232530-Breaker bar

2004232524-Cyclic quaternary amino derivatives as modulators of chemokine receptors